关注
Kathryn "Katie" Czepiel
Kathryn "Katie" Czepiel
Pediatric Gastroenterology Fellow
在 mgh.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Pharmacotherapy for the treatment of overweight and obesity in children, adolescents, and young adults in a large health system in the US
KS Czepiel, NP Perez, KJ Campoverde Reyes, S Sabharwal, FC Stanford
Frontiers in Endocrinology 11, 290, 2020
502020
Treatment of obesity: pharmacotherapy trends of office-based visits in the United States from 2011 to 2016
MD Claridy, KS Czepiel, SS Bajaj, FC Stanford
Mayo Clinic Proceedings 96 (12), 2991-3000, 2021
212021
Exploring pediatric obesity training, perspectives, and management patterns among pediatric primary care physicians
KJ Campoverde Reyes, NP Perez, KS Czepiel, AY Shaw, FC Stanford
Obesity 29 (1), 159-170, 2021
172021
Dexmedetomidine-associated hyperpyrexia in three critically ill patients with coronavirus disease 2019
KS Czepiel, AT Lucas, MJ Whalen, JE Mojica
Critical care explorations 2 (9), e0213, 2020
172020
Food as medicine for obesity treatment and management
VR Johnson, TB Washington, S Chhabria, EHC Wang, K Czepiel, ...
Clinical therapeutics 44 (5), 671-681, 2022
152022
Preoperative considerations for the pediatric patient undergoing metabolic and bariatric surgery
JSA Pratt, SS Roque, R Valera, KS Czepiel, DD Tsao, FC Stanford
Seminars in pediatric surgery 29 (1), 150890, 2020
132020
Bariatric surgery in the treatment of adolescent obesity: current perspectives in the United States
S Malhotra, KS Czepiel, EY Akam, AY Shaw, R Sivasubramanian, ...
Expert review of endocrinology & metabolism 16 (3), 123-134, 2021
122021
Strategies in the management of adolescent obesity
VR Johnson, M Cao, KS Czepiel, T Mushannen, LS Nolen, FC Stanford
Current pediatrics reports 8, 56-65, 2020
82020
Pharmacotherapy for weight loss in children, adolescents, and young adults: an evaluation of current on-and off-label usage
KS Czepiel, NP Perez, KJ Campoverde Reyes, S Sabharwal, FC Stanford
Pediatrics 147 (3_MeetingAbstract), 180-181, 2021
22021
They didn’t cover this in lecture: the formation and dissolution of the patient-provider relationship
KS Czepiel
Perspectives on Medical Education 7, 16-17, 2018
12018
The Many Names of Fatty Liver Disease: Strengths and Limitations of Metabolic (Dysfunction)-Associated Fatty Liver Disease
KS Czepiel, FC Stanford
Childhood Obesity 19 (1), 1-2, 2023
2023
Association Between Weight Promoting Medication Use and Weight Status Among Children and Adolescents in the United States
MD Claridy, NP Perez, KS Czepiel, NO Acholonu, FC Stanford
Academic pediatrics 23 (1), 102-108, 2023
2023
Haploinsufficiency of NPM1 in AML Derived NPM1 Mutant (NPMc+) Expressing Cells Contributes to Aberrant C/EBPα Activity
K Czepiel, K Nichol, M Tippy, N Abayasekara, J Lee, E Wajswol, ...
Blood 124 (21), 2188, 2014
2014
系统目前无法执行此操作,请稍后再试。
文章 1–13